ACEi and ARBS in Hypertension and Heart Failure

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book ACEi and ARBS in Hypertension and Heart Failure by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319097886
Publisher: Springer International Publishing Publication: October 16, 2014
Imprint: Springer Language: English
Author:
ISBN: 9783319097886
Publisher: Springer International Publishing
Publication: October 16, 2014
Imprint: Springer
Language: English

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

More books from Springer International Publishing

Cover of the book India in the American Imaginary, 1780s–1880s by
Cover of the book Handbook of Biometric Anti-Spoofing by
Cover of the book The Origins of Asset Management from 1700 to 1960 by
Cover of the book Numerical Approximation of the Magnetoquasistatic Model with Uncertainties by
Cover of the book Textbook of Rapid Response Systems by
Cover of the book Heart Rate Variability Analysis with the R package RHRV by
Cover of the book Advances in 3D Geoinformation by
Cover of the book Arts, Research, Innovation and Society by
Cover of the book Absolute Dermatology Review by
Cover of the book Visualization of Conventional and Combusting Subsonic Jet Instabilities by
Cover of the book Diagnosis and Endoscopic Management of Digestive Diseases by
Cover of the book Political Landscapes of the Late Intermediate Period in the Southern Andes by
Cover of the book Biomedical Signals and Sensors III by
Cover of the book After Brexit by
Cover of the book Renewable Energy in the Service of Mankind Vol II by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy